XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Net patient revenues $ 328,674,000 $ 277,005,000 $ 894,415,000 $ 804,617,000
Other revenues 11,524,000 11,480,000 34,172,000 36,013,000
Government stimulus income 0 0 9,445,000 0
Net operating revenues and grant income 340,198,000 288,485,000 938,032,000 840,630,000
Costs and expenses:        
Salaries, wages, and benefits 213,395,000 182,664,000 576,609,000 525,782,000
Other operating 82,509,000 72,490,000 238,092,000 217,213,000
Facility rent 10,886,000 10,094,000 31,804,000 30,087,000
Depreciation and amortization 10,619,000 10,135,000 30,543,000 30,266,000
Interest 1,742,000 77,000 1,788,000 268,000
Total costs and expenses 319,151,000 275,460,000 878,836,000 803,616,000
Income from operations 21,047,000 13,025,000 59,196,000 37,014,000
Other income:        
Non–operating income 4,224,000 4,097,000 14,865,000 12,116,000
Unrealized gains on marketable equity securities 32,767,000 (3,093,000) 56,290,000 2,943,000
Income before income taxes 58,038,000 14,029,000 130,351,000 52,073,000
Income tax provision (15,338,000) (3,908,000) (34,294,000) (14,750,000)
Net income 42,700,000 10,121,000 96,057,000 37,323,000
Net (income)/loss attributable to noncontrolling interest 89,000 267,000 (211,000) 1,069,000
Net income attributable to National HealthCare Corporation $ 42,789,000 $ 10,388,000 $ 95,846,000 $ 38,392,000
Earnings per share attributable to National HealthCare Corporation stockholders:        
Basic (in dollars per share) $ 2.78 $ 0.68 $ 6.23 $ 2.51
Diluted (in dollars per share) $ 2.73 $ 0.68 $ 6.15 $ 2.5
Weighted average common shares outstanding:        
Basic (in shares) 15,411,680 15,299,913 15,384,758 15,311,453
Diluted (in shares) 15,667,321 15,324,511 15,576,294 15,334,269
Dividends declared per common share (in dollars per share) $ 0.61 $ 0.59 $ 1.81 $ 1.75